Michael Aaron Kelly - 30 Jun 2022 Form 4 Insider Report for HOOKIPA Pharma Inc. (HOOK)

Role
Director
Signature
/s/ Reinhard Kandera, as Attorney-in-Fact
Issuer symbol
HOOK
Transactions as of
30 Jun 2022
Transactions value $
$0
Form type
4
Filing time
01 Jul 2022, 16:09:41
Previous filing
14 Jun 2022
Next filing
19 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOOK Stock Option (Right to Buy) Award $0 +20K $0.00 20K 30 Jun 2022 Common Stock 20K $1.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become fully exercisable on June 30, 2023.